Ph.D., economics, Boston University; M.A., economics, Universitat Pompeu Fabra; B.A., mathematics, University of Pennsylvania
Summary of Experience
Dr. Goldschmidt is an economist who specializes in the application of statistics and econometrics to health economics and outcomes research (HEOR). Her work includes medical chart reviews, retrospective claims analyses, physician surveys, surveys of the general public, and clinical trial analyses. Dr. Goldschmidt has conducted research in a range of disease areas, including oncology, neurology, and immunology. Her research has been published in peer-reviewed journals and presented at clinical and health economics research conferences. Prior to joining Analysis Group, Dr. Goldschmidt worked at two financial services firms.
Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2- Metastatic Breast Cancer
Advances in Therapy. 2018 Aug;35(8):1251-1264
Current Treatment Patterns Among Postmenopausal Women with HR+/HER2- Metastatic Breast Cancer in US Community Oncology Practices: An Observational Study
Advances in Therapy. 26 Mar 2018:1-12